Skip to content
10-Q

Quarterly Report

IRONWOOD PHARMACEUTICALS INC IRWD

0001558370-25-011050

← back to feed
Filed
Aug 11, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 162.43M sh
Shares Diluted Q2 2025 · Jun 30, 2025 176.84M sh
Shares Diluted Q2 2025 · Jun 30, 2025 161.35M sh
Shares Diluted Q2 2025 · Jun 30, 2024 159.01M sh
Shares Diluted Q2 2025 · Jun 30, 2024 158.36M sh
Capex Q2 2025 · Jun 30, 2025 $33K
Capex Q2 2025 · Jun 30, 2024 $126K
Operating Cash Flow Q2 2025 · Jun 30, 2025 $4.89M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $78.45M
Long Term Debt Q2 2025 · Jun 30, 2025 $199.33M
Long Term Debt Q2 2025 · Dec 31, 2024 $198.99M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $92.85M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $88.56M
Stockholders Equity Q2 2025 · Jun 30, 2025 −$308.16M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$301.34M
Current Liabilities Q2 2025 · Jun 30, 2025 $232.53M
Current Liabilities Q2 2025 · Dec 31, 2024 $38.85M
Current Assets Q2 2025 · Jun 30, 2025 $191.75M
Current Assets Q2 2025 · Dec 31, 2024 $182.37M
Total Assets Q2 2025 · Jun 30, 2025 $342.95M
Total Assets Q2 2025 · Dec 31, 2024 $350.91M
Eps Diluted Q2 2025 · Jun 30, 2025 $0.14
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.09
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.01
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.03
Eps Basic Q2 2025 · Jun 30, 2025 $0.15
Eps Basic Q2 2025 · Jun 30, 2025 −$0.09
Eps Basic Q2 2025 · Jun 30, 2024 −$0.01
Eps Basic Q2 2025 · Jun 30, 2024 −$0.03
Sga Expense Q2 2025 · Jun 30, 2025 $16.8M
Sga Expense Q2 2025 · Jun 30, 2025 $41.06M
Sga Expense Q2 2025 · Jun 30, 2024 $36.96M
Sga Expense Q2 2025 · Jun 30, 2024 $74.57M
Rd Expense Q2 2025 · Jun 30, 2025 $23.37M
Rd Expense Q2 2025 · Jun 30, 2025 $50.81M
Rd Expense Q2 2025 · Jun 30, 2024 $30.39M
Rd Expense Q2 2025 · Jun 30, 2024 $56.2M
Net Income Q2 2025 · Jun 30, 2025 $23.6M
Net Income Q2 2025 · Jun 30, 2025 −$13.79M
Net Income Q2 2025 · Jun 30, 2024 −$860K
Net Income Q2 2025 · Jun 30, 2024 −$5.02M
Operating Income Q2 2025 · Jun 30, 2025 $45.32M
Operating Income Q2 2025 · Jun 30, 2025 $16.21M
Operating Income Q2 2025 · Jun 30, 2024 $24.98M
Operating Income Q2 2025 · Jun 30, 2024 $36M
Revenue Q2 2025 · Jun 30, 2025 $85.24M
Revenue Q2 2025 · Jun 30, 2025 $126.38M
Revenue Q2 2025 · Jun 30, 2024 $94.4M
Revenue Q2 2025 · Jun 30, 2024 $169.27M